A Study of Elranatamab and Cyclophosphamide in People With Multiple Myeloma

NCT07454382 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

26

Enrollment

OTHER

Sponsor class

Conditions

Multiple Myeloma

Interventions

BIOLOGICAL: Elranatamab-bcmm
DRUG: Cyclophosphamide

Sponsor

Memorial Sloan Kettering Cancer Center

Collaborators

[object Object]